Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors

被引:74
|
作者
Mathew, Bijo [1 ,2 ]
Haridas, Abitha [3 ]
Ucar, Gulberk [4 ]
Baysal, Ipek [4 ]
Adeniyi, Adebayo A. [5 ]
Soliman, Mahmoud E. S. [5 ]
Joy, Monu [6 ]
Mathew, Githa Elizabeth [7 ]
Lakshmanan, Baskar [3 ]
Jayaprakash, Venkatesan [8 ]
机构
[1] Ahalia Sch Pharm, Div Drug Design, Palakkad 678557, Kerala, India
[2] Ahalia Sch Pharm, Med Chem Res Lab, Dept Pharmaceut Chem, Palakkad 678557, Kerala, India
[3] Grace Coll Pharm, Dept Pharmaceut Chem, Palakkad 678004, Kerala, India
[4] Hacettepe Univ, Dept Biochem, Fac Pharm, TR-06100 Ankara, Turkey
[5] Univ KwaZulu Natal, Sch Hlth Sci, ZA-4001 Durban, South Africa
[6] MG Univ, Sch Pure & Appl Phys, Kottayam, Kerala, India
[7] Grace Coll Pharm, Dept Pharmacol, Palakkad 678004, Kerala, India
[8] Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi 835215, Jharkhand, India
关键词
Thienyl chalcones; Human monoamine oxidase; Molecular docking; Molecular dynamics; ACCELERATED MOLECULAR-DYNAMICS; CURCUMIN-BASED DESIGN;
D O I
10.1016/j.ijbiomac.2016.05.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chalcone has been reported to be a valid scaffold for the design of monoamine oxidase (MAO) inhibitors. This scenario has amplified the momentum for the discovery of heteroaryl based chalcone MAO inhibitors. In the present study, we have synthesized a series of eleven chlorinated thienyl chalcone derivatives substituted with a different functional groups at the para- position on the ring B and investigated for their ability to inhibit human MAO-A and-B. With the exception of compound (2E)-1-(4-chlorocyclopental,3-dien-1-yl)-3-(4-nitrophenyl)prop-2-en-1-one (TC7), which was a selective MAO-A inhibitor, all the other derivatives inhibited hMAO-B potently and selectively with competitive mode of inhibition. The most potent compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-ethylphenyl)prop-2-en-1-one (TC6) was found to be the best activity and higher selectivity towards hMAO-B with Ki and SI values of 0.31 +/- 0.02 mu M and 16.84, respectively. All the compounds presented in the current study are completely non-toxic with 74-88% viable cells to hepatic cells at 100 M concentration. Molecular docking and molecular dynamics simulation studies were carried out using Autodock-4.2 and Amber 14 to understand the molecular level interaction and energy relation of MAO isoforms with selective MAO-B inhibitor TC6. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:680 / 695
页数:16
相关论文
共 50 条
  • [1] Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones
    Singh, Ashutosh Kumar
    Kim, Seong-Min
    Oh, Jong Min
    Abdelgawad, Mohamed A.
    Ghoneim, Mohammed M.
    Rangarajan, T. M.
    Kumar, Sunil
    Sudevan, Sachithra Thazhathuveedu
    Trisciuzzi, Daniela
    Nicolotti, Orazio
    Kim, Hoon
    Mathew, Bijo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (02) : 271 - 284
  • [2] Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
    Rehuman, Nisha Abdul
    Oh, Jong Min
    Nath, Lekshmi R.
    Khames, Ahmed
    Abdelgawad, Mohamed A.
    Gambacorta, Nicola
    Nicolotti, Orazio
    Jat, Rakesh Kumar
    Kim, Hoon
    Mathew, Bijo
    ACS OMEGA, 2021, 6 (42): : 28182 - 28193
  • [3] Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors
    Hammuda, Arwa
    Shalaby, Raed
    Rovida, Stefano
    Edmondson, Dale E.
    Binda, Claudia
    Khalil, Ashraf
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 114 : 162 - 169
  • [4] Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors
    Sasidharan, Rani
    Baek, Seung Cheol
    Manju, Sreedharannair Leelabaiamma
    Kim, Hoon
    Mathew, Bijo
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 106 : 8 - 13
  • [5] Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease
    Reeta
    Baek, Seung Cheol
    Lee, Jae Pil
    Rangarajan, T. M.
    Ayushee
    Singh, Rishi Pal
    Singh, Manjula
    Mangiatordi, Giuseppe Felice
    Nicolotti, Orazio
    Kim, Hoon
    Mathew, Bijo
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (08) : 643 - 654
  • [6] Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase-B inhibitors
    Sudevan, Sachithra T.
    Rangarajan, T. M.
    Al-Sehemi, Abdullah G.
    Nair, Aathira S.
    Koyiparambath, Vishal P.
    Mathew, Bijo
    ARCHIV DER PHARMAZIE, 2022, 355 (08)
  • [7] SELECTIVE INHIBITORS OF MONOAMINE OXIDASE-A AND OXIDASE-B
    WILLIAMS, CH
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (02) : 334 - 337
  • [8] Design of enamides as new selective monoamine oxidase-B inhibitors
    Kavully, Fathima Sahla
    Oh, Jong Min
    Dev, Sanal
    Kaipakasseri, Swafvan
    Palakkathondi, Ashique
    Vengamthodi, Ajeesh
    Azeez, Rinshana Fathima Abdul
    Tondo, Anna Rita
    Nicolotti, Orazio
    Kim, Hoon
    Mathew, Bijo
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (07) : 916 - 926
  • [9] VINBLASTINE AND VINCRISTINE ARE INHIBITORS OF MONOAMINE OXIDASE-B
    SON, JK
    ROSAZZA, JPN
    DUFFEL, MW
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1845 - 1848
  • [10] NEW DIRECTIONS IN MONOAMINE OXIDASE-A AND OXIDASE-B - SELECTIVE INHIBITORS AND SUBSTRATES
    YOUDIM, MBH
    FINBERG, JPM
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (02) : 155 - 162